Litcius/Paper detail

Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial

Chipepo Kankasa, Anaïs Mennecier, Béninwendé Leticia Delphine Sakana, Jean‐Pierre Molès, Mwiya Mwiya, Catherine Chunda‐Liyoka, Morgana D’Ottavi, Souleymane Tassembédo, Maria Melany Wilfred-Tonga, Paulin Fao, David Rutagwera, Beauty Matoka, Dramane Kania, Ousmane A Taofiki, Thorkild Tylleskär, Philippe Van de Perre, Nicolas Nagot

2024The Lancet11 citationsDOI

Topics & Concepts

BreastfeedingMedicineLamivudineTransmission (telecommunications)Human immunodeficiency virus (HIV)Viral loadAntiretroviral therapyPostnatal CarePediatricsBreast feedingPregnancyObstetricsVirologyBiologyVirusGeneticsElectrical engineeringEngineeringHepatitis B virusHIV/AIDS Research and InterventionsMobile Health and mHealth ApplicationsCytomegalovirus and herpesvirus research
Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial | Litcius